1301-27-R-RFIN-00006

The Mississippi State Department of Health, Mississippi Public Health Laboratory (MPHL), is proposing a sole-source purchase of QuantiFERON-TB Gold Plus reagent kits and control materials from QIAGEN for FDA-approved tuberculosis interferon-gamma release assay (IGRA) testing, with the objection deadline of November 9, 2026 at 10:00 a.m. CST. This is a sole-source procurement, not a competitive solicitation; objections to the sole-source designation must be submitted in writing to Cynthia Brasher at the MPHL Purchasing Department by the deadline.

The scope comprises QIAGEN LIAISON platform products: QuantiFERON-TB Gold Plus test kits (50-test format), control reagents for the Gold Plus test, QFT-Plus II test kits, QFT-Plus II control reagents, and collection tubes in multiple configurations. All materials are FDA-approved for on-site IGRA testing of human patients. Quantities total 40 units of test kits, 30 units of control reagents per formulation, and 80 units of collection tubes.

The total extended price is $121,160, with individual unit prices ranging from $250 to $940. The sole-source justification rests on MPHL's current reliance on QIAGEN's QuantiFERON-TB Gold Plus platform as the modern alternative to traditional tuberculin skin testing. Any objector must provide detailed written evidence and documentation that alternative sources supply the same commodity. If the MPHL determines alternative sources exist following objection review, the procurement converts to advertised competitive bidding. If the sole-source designation is upheld, the department appeals to the Public Procurement Review Board, which bears the burden of proving that only QIAGEN provides the required commodity.